EN FR

Creating new alternative protein options with special nutritional requirements

Technology
Technology Leadership Priority

Products

PROJECT TIMELINE
February 2024 to November 2026
PROJECT STATUS
Fund II: In progress
TOTAL INVESTMENT
$5,455,495

Consortia Contribution
$3,106,522

Cluster Contribution
$2,348,973

Partners

Enhanced Medical Nutrition

Acenzia

Gruppo Nutrition

Goal

To bring new protein products for Canadians with special nutritional requirements.

Project Summary

The project partners are utilizing innovative solutions to offer alternative plant-based protein options that meet the quality, sensory and muscle health benefits of whey protein isolate. The project will see the development, reformulation and commercialization, of three consumer-ready protein products: a modular, a ready-to-mix and a ready-to-drink low-volume liquid protein.

In addition to options that address medical nutrition needs, including those associated with surgery, critical illness and chronic disease, this project will also create products for the active living and high-performance sports markets. The end products will contain a novel plant-based protein ingredient blend with high functionality and taste quality, reformulated from a past project.

Building from EMN and Gruppo Nutrition’s previous project of creating the original ingredient blend, this project will reformulate the blend using new inputs of yellow pea and canola protein isolates, while also researching other potential protein isolate options, such as hemp and sunflower. EMN and Gruppo Nutrition will collaborate with Acenzia to optimize manufacturing processes, to expand their consumer-ready products within current and new markets. This commercial scaling will allow for a larger return on investment for the consortium, product end-users and the sector.

Related reading